Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer

Prostate cancer patients who undergo radiotherapy are at an increased risk to develop a radiogenic second cancer. Proton therapy has been shown to reduce the predicted risk of second cancer when compared to intensity modulated radiotherapy. However, it is unknown if this is also true for the rotational therapies proton arc therapy and volumetric modulated arc therapy (VMAT). The objective of this study was to compare the predicted risk of cancer following proton arc therapy and VMAT for prostate cancer. Proton arc therapy and VMAT plans were created for three patients. Various risk models were combined with the dosimetric data (therapeutic and stray dose) to predict the excess relative risk (ERR) of cancer in the bladder and rectum. Ratios of ERR values (RRR) from proton arc therapy and VMAT were calculated. RRR values ranged from 0.74 to 0.99, and all RRR values were shown to be statistically less than 1, except for the value calculated with the linear-non-threshold risk model. We conclude that the predicted risk of cancer in the bladder or rectum following proton arc therapy for prostate cancer is either less than or approximately equal to the risk following VMAT, depending on which risk model is applied.

[1]  Yan Liu,et al.  Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study , 2005, The Lancet.

[2]  Barbara Kaser-Hotz,et al.  The Impact of IMRT and Proton Radiotherapy on Secondary Cancer Incidence , 2006, Strahlentherapie und Onkologie.

[3]  W E Bolch,et al.  Individual variations in mucosa and total wall thickness in the stomach and rectum assessed via endoscopic ultrasound. , 2003, Physiological measurement.

[4]  Cedric X. Yu,et al.  Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy. , 1995, Physics in medicine and biology.

[5]  T. Mackie,et al.  Maximum proton kinetic energy and patient-generated neutron fluence considerations in proton beam arc delivery radiation therapy. , 2009, Medical physics.

[6]  P. Keall,et al.  Determination of maximum leaf velocity and acceleration of a dynamic multileaf collimator: implications for 4D radiotherapy. , 2005, Medical physics.

[7]  Andrew K. Lee,et al.  Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. , 2009, International journal of radiation oncology, biology, physics.

[8]  Karl Otto,et al.  Volumetric modulated arc therapy: IMRT in a single gantry arc. , 2007, Medical physics.

[9]  Barbara Kaser-Hotz,et al.  Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. , 2005, International journal of radiation oncology, biology, physics.

[10]  Harald Paganetti,et al.  Relative biological effectiveness (RBE) values for proton beam therapy. , 2002, International journal of radiation oncology, biology, physics.

[11]  H. Tsujii,et al.  ICRU Report No. 78, Prescribing, recording, and reporting proton-beam therapy. , 2007 .

[12]  G. Sandison,et al.  Phantom assessment of lung dose from proton arc therapy. , 1997, International journal of radiation oncology, biology, physics.

[13]  M. Valenti,et al.  The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness. , 1998, The Journal of urology.

[14]  D. Brenner,et al.  Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery , 2000, Cancer.

[15]  Alexandru Daşu,et al.  Dose-effect models for risk – relationship to cell survival parameters , 2005, Acta oncologica.

[16]  S. Kry,et al.  Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy , 2010, Physics in medicine and biology.

[17]  M. Gail,et al.  Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. , 2005, Journal of the National Cancer Institute.

[18]  M. Kaus,et al.  Development and evaluation of an efficient approach to volumetric arc therapy planning. , 2009, Medical physics.

[19]  C. Clark,et al.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice. , 2011, The British journal of radiology.

[20]  K A Lindsay,et al.  Radiation carcinogenesis modelling for risk of treatment-related second tumours following radiotherapy. , 2001, The British journal of radiology.

[21]  R Jeraj,et al.  Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study , 2007, Physics in medicine and biology.

[22]  T R Mackie,et al.  A compact linac for intensity modulated proton therapy based on a dielectric wall accelerator. , 2008, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[23]  B. Bednarz,et al.  A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models. , 2010, Medical physics.

[24]  Daniel W. Miller,et al.  Methodologies and tools for proton beam design for lung tumors. , 2001, International journal of radiation oncology, biology, physics.

[25]  E. Hall.  Henry S. Kaplan Distinguished Scientist Award 2003The crooked shall be made straight; dose–response relationships for carcinogenesis , 2004, International journal of radiation biology.

[26]  Paul DeLuca,et al.  Realistic reference phantoms: An ICRP/ICRU joint effort , 2009, Annals of the ICRP.

[27]  W. Newhauser,et al.  Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit , 2008, Physics in medicine and biology.

[28]  U Titt,et al.  Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: a Monte Carlo study. , 2005, Radiation protection dosimetry.

[29]  J. Ruben,et al.  The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. , 2008, International journal of radiation oncology, biology, physics.

[30]  Marco Durante,et al.  Assessing the risk of second malignancies after modern radiotherapy , 2011, Nature Reviews Cancer.

[31]  Andrew K. Lee,et al.  Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer , 2008, Physics in medicine and biology.

[32]  R. Sievert,et al.  Book Reviews : Recommendations of the International Commission on Radiological Protection (as amended 1959 and revised 1962). I.C.R.P. Publication 6. 70 pp. PERGAMON PRESS. Oxford, London and New York, 1964. £1 5s. 0d. [TB/54] , 1964 .

[33]  Joel E Tepper,et al.  Increased risk of rectal cancer after prostate radiation: a population-based study. , 2005, Gastroenterology.

[34]  Division on Earth.  Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2 , 2006 .

[35]  G. Nicholas,et al.  Second primary cancers after prostatic irradiation: Ensuring an appropriate analysis , 2007, Cancer.

[36]  S. Kry,et al.  Accuracy of out-of-field dose calculations by a commercial treatment planning system , 2010, Physics in medicine and biology.

[37]  U. Schneider,et al.  A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy. , 2005, Zeitschrift fur medizinische Physik.

[38]  D. Followill,et al.  Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy , 2010, Physics in medicine and biology.

[39]  Stine Korreman,et al.  RapidArc volumetric modulated therapy planning for prostate cancer patients , 2009, Acta oncologica.

[40]  Barbara Kaser-Hotz,et al.  The impact of dose escalation on secondary cancer risk after radiotherapy of prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[41]  U Oelfke,et al.  Intensity modulated radiotherapy with charged particle beams: studies of inverse treatment planning for rotation therapy. , 2000, Medical physics.

[42]  J. Valentin.  Basic anatomical and physiological data for use in radiological protection: reference values , 2002, Annals of the ICRP.

[43]  D. Theodorescu,et al.  Cancer incidence after localized therapy for prostate cancer , 2006, Cancer.

[44]  Yan Liu,et al.  Thyroid Cancer in Childhood Cancer Survivors: A Detailed Evaluation of Radiation Dose Response and its Modifiers , 2006, Radiation research.

[45]  A. Jemal,et al.  Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[46]  U Isacsson,et al.  Potential advantages of protons over conventional radiation beams for paraspinal tumours. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[47]  Jack Valentin,et al.  Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR) , 2003 .

[48]  M. Moyers,et al.  Range, Range Modulation, and Field Radius Requirements for Proton Therapy of Prostate Cancer , 2003, Technology in cancer research & treatment.

[49]  Thomas Pasko,et al.  Physician Characteristics and Distribution in the Us: 1999 , 1998 .

[50]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[51]  D. Kuban,et al.  The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. , 2005, International journal of radiation oncology, biology, physics.

[52]  E. Hall,et al.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.

[53]  Radhe Mohan,et al.  Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm , 2007, Physics in medicine and biology.

[54]  Andrew Jackson,et al.  Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. , 2010, International journal of radiation oncology, biology, physics.

[55]  D. Brenner,et al.  Secondary neutrons in clinical proton radiotherapy: a charged issue. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.